Management of Molar Pregnancy During COVID-19 Pandemic
Novelty in Biomedicine,
Vol. 10 No. 2 (2022),
9 May 2022
,
Page 140-141
https://doi.org/10.22037/nbm.v10i2.36722
Abstract
Molar pregnancy is a group of diseases called gestational trophoblastic disease (GTD) that originates in the placenta and has the potential to invade the uterus and metastasize locally1, 2. During the past months, the novel coronavirus disease 2019 (COVID-19) has been responsible for the worldwide pandemic3. Patients usually go to the hospital only if they need high emergency aid or have a high-risk condition in this quarantine situation. Hence, this situation can impact diagnosing and managing benign and malignant molar pregnancy, and the diagnosis might be delayed.
- Coronavirus, Molar Pregnancy, Management, Covid-19
How to Cite
References
Berkowitz RS, Goldstein DP. Current advances in the management of the gestational trophoblastic disease. Gynecologic oncology. 2013;128(1):3-5.
Sanchez-Ramos L. Gestational Trophoblastic Neoplasia After Human Chorionic Gonadotropin Normalization Following Molar Pregnancy: A Systematic Review and Meta-Analysis. Obstetrics & Gynecology. 2020;135(5):1225-6.
Lu Q, Shi Y. Coronavirus disease (COVID‐19) and neonate: What neonatologist need to know. Journal of medical virology. 2020;92(6):564-7.
Elias KM, Berkowitz RS, Horowitz NS. State-of-the-Art workup and initial management of newly diagnosed molar pregnancy and postmolar gestational trophoblastic neoplasia. Journal of the National Comprehensive Cancer Network. 2019;17(11):1396-401.
Berkowitz RS, Goldstein DP, Horowitz NS, Dizon DS, Vora SR. Initial management of low-risk gestational trophoblastic neoplasia. UpToDate Waltham, MA: UpToDate. 2019.
- Abstract Viewed: 221 times
- pdf Downloaded: 163 times